Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Rzasa

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Molecular Syndromology|July 11, 2026
Complimentary Episignature Testing for Variant Reclassification: Case Reports with Variant Classification Guideline ConsiderationPratibha Bawa, Jessica Rzasa, Jennifer Kerkhof, et al.
Frontiers in Genetics|June 8, 2026
Episignature leads to diagnosis and reclassification of DYRK1A variant in a child with syndromic neurodevelopmental disorder: a case reportInas Al-Younis, Laurence Basque, Nicolas Crapoulet, et al.
Clinical Genetics|November 27, 2024
Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical ManifestationsLisa Pavinato, Silvia Carestiato, Slavica Trajkova, et al.
Clinical Epigenetics|April 10, 2026
Chromatinopathies: clinically overlapping disorders, revealing novel variants and their DNA methylation signaturesAsuman Koparir, Jennifer Kerkhof, Jessica Rzasa, et al.
Clinical Epigenetics|June 13, 2026
Correction: Chromatinopathies: clinically overlapping disorders, revealing novel variants and their DNA methylation signaturesAsuman Koparir, Jennifer Kerkhof, Jessica Rzasa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2025
Discovery of a DNA methylation episignature as a molecular biomarker for fetal alcohol syndromeLiselot van der Laan, Raissa Relator, Irene Valenzuela, et al.
Molecular Neurobiology|December 15, 2024
EHMT2 as a Candidate Gene for an Autosomal Recessive Neurodevelopmental SyndromeLaura Machado Lara Carvalho, Jessica Rzasa, Jennifer Kerkhof, et al.
The Journal of Clinical Endocrinology and Metabolism|July 30, 2024
Congenital Hyperinsulinism and Novel KDM6A Duplications -Resolving Pathogenicity With Genome and Epigenetic AnalysesJonna M E Männistö, Jasmin J Hopkins, Thomas I Hewat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2025
DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like TumorsLucy Wang, Varshini Vasudevaraja, Jonathan Serrano, et al.
American Journal of Hematology|November 17, 2025
DNA Methylation Episignature as a Novel Diagnostic Tool for Diamond-Blackfan Anemia SyndromePaola Quarello, Karim Karimi, Slavica Trajkova, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Molecular Syndromology|July 11, 2026
Complimentary Episignature Testing for Variant Reclassification: Case Reports with Variant Classification Guideline ConsiderationPratibha Bawa, Jessica Rzasa, Jennifer Kerkhof, et al.
Frontiers in Genetics|June 8, 2026
Episignature leads to diagnosis and reclassification of DYRK1A variant in a child with syndromic neurodevelopmental disorder: a case reportInas Al-Younis, Laurence Basque, Nicolas Crapoulet, et al.
Clinical Genetics|November 27, 2024
Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical ManifestationsLisa Pavinato, Silvia Carestiato, Slavica Trajkova, et al.
Clinical Epigenetics|April 10, 2026
Chromatinopathies: clinically overlapping disorders, revealing novel variants and their DNA methylation signaturesAsuman Koparir, Jennifer Kerkhof, Jessica Rzasa, et al.
Clinical Epigenetics|June 13, 2026
Correction: Chromatinopathies: clinically overlapping disorders, revealing novel variants and their DNA methylation signaturesAsuman Koparir, Jennifer Kerkhof, Jessica Rzasa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2025
Discovery of a DNA methylation episignature as a molecular biomarker for fetal alcohol syndromeLiselot van der Laan, Raissa Relator, Irene Valenzuela, et al.
Molecular Neurobiology|December 15, 2024
EHMT2 as a Candidate Gene for an Autosomal Recessive Neurodevelopmental SyndromeLaura Machado Lara Carvalho, Jessica Rzasa, Jennifer Kerkhof, et al.
The Journal of Clinical Endocrinology and Metabolism|July 30, 2024
Congenital Hyperinsulinism and Novel KDM6A Duplications -Resolving Pathogenicity With Genome and Epigenetic AnalysesJonna M E Männistö, Jasmin J Hopkins, Thomas I Hewat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2025
DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like TumorsLucy Wang, Varshini Vasudevaraja, Jonathan Serrano, et al.
American Journal of Hematology|November 17, 2025
DNA Methylation Episignature as a Novel Diagnostic Tool for Diamond-Blackfan Anemia SyndromePaola Quarello, Karim Karimi, Slavica Trajkova, et al.
Pageof 3